Literature DB >> 27670945

Regulation of the IL-10-driven macrophage phenotype under incoherent stimuli.

Yishan Chuang1, Michelle E Hung2, Brianne K Cangelose1, Joshua N Leonard1,2,3,4.   

Abstract

Macrophages are ubiquitous innate immune cells that play a central role in health and disease by adopting distinct phenotypes, which are broadly divided into classical inflammatory responses and alternative responses that promote immune suppression and wound healing. Although macrophages are attractive therapeutic targets, incomplete understanding of this functional choice limits clinical manipulation. While individual stimuli, pathways, and genes involved in macrophage functional responses have been identified, how macrophages evaluate complex in vivo milieus comprising multiple divergent stimuli remains poorly understood. Here, we used combinations of "incoherent" stimuli-those that individually promote distinct macrophage phenotypes-to elucidate how the immunosuppressive, IL-10-driven macrophage phenotype is induced, maintained, and modulated under such combinatorial stimuli. The IL-10-induced immunosuppressive phenotype was largely insensitive to co-administered IL-12, which has been reported to modulate macrophage phenotype, but maintaining the immunosuppressive phenotype required sustained exposure to IL-10. Our data implicate the intracellular protein, BCL3, as a key mediator of the IL-10-driven phenotype. Notably, co-administration of IFN-γ disrupted an IL-10-mediated positive feedback loop that may reinforce the immunosuppressive phenotype. This novel combinatorial perturbation approach thus generated new insights into macrophage decision making and local immune network function.

Entities:  

Keywords:  Interleukin-10 (IL-10); macrophage polarization; macrophages; tumor-associated macrophages (TAM)

Mesh:

Substances:

Year:  2016        PMID: 27670945      PMCID: PMC5292318          DOI: 10.1177/1753425916668243

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  72 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 2.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

3.  IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo.

Authors:  Stephanie K Watkins; Nejat K Egilmez; Jill Suttles; Robert D Stout
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

4.  The origin and function of tumor-associated macrophages.

Authors:  Yang Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2014-09-15       Impact factor: 11.530

5.  Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines.

Authors:  Steven J Kattman; Alec D Witty; Mark Gagliardi; Nicole C Dubois; Maryam Niapour; Akitsu Hotta; James Ellis; Gordon Keller
Journal:  Cell Stem Cell       Date:  2011-02-04       Impact factor: 24.633

Review 6.  HMGB1 and RAGE in inflammation and cancer.

Authors:  Gary P Sims; Daniel C Rowe; Svend T Rietdijk; Ronald Herbst; Anthony J Coyle
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

7.  Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.

Authors:  Lynn Williams; Laura Bradley; Alexandra Smith; Brian Foxwell
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

8.  SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor beta2 subunit.

Authors:  Koh Yamamoto; Mitsuko Yamaguchi; Nobuyuki Miyasaka; Osamu Miura
Journal:  Biochem Biophys Res Commun       Date:  2003-10-31       Impact factor: 3.575

Review 9.  Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).

Authors:  Eléonore Beurel; Suzanne M Michalek; Richard S Jope
Journal:  Trends Immunol       Date:  2009-10-14       Impact factor: 16.687

Review 10.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

View more
  18 in total

1.  Active Delivery of VLPs Promotes Anti-Tumor Activity in a Mouse Ovarian Tumor Model.

Authors:  Chao Wang; Berta Esteban Fernández de Ávila; Rodolfo Mundaca-Uribe; Miguel Angel Lopez-Ramirez; Doris E Ramírez-Herrera; Sourabh Shukla; Nicole F Steinmetz; Joseph Wang
Journal:  Small       Date:  2020-04-24       Impact factor: 13.281

Review 2.  Therapeutic cancer vaccines.

Authors:  Mansi Saxena; Sjoerd H van der Burg; Cornelis J M Melief; Nina Bhardwaj
Journal:  Nat Rev Cancer       Date:  2021-04-27       Impact factor: 60.716

3.  Latest advances to enhance the therapeutic potential of mesenchymal stromal cells for the treatment of immune-mediated diseases.

Authors:  Angela Ceruso; Ainhoa Gonzalez-Pujana; Manoli Igartua; Edorta Santos-Vizcaino; Rosa Maria Hernandez
Journal:  Drug Deliv Transl Res       Date:  2021-02-25       Impact factor: 4.617

4.  High-capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma.

Authors:  Natasha Vinod; Duhyeong Hwang; Salma H Azam; Amanda E D Van Swearingen; Elizabeth Wayne; Sloane Christian Fussell; Marina Sokolsky-Papkov; Chad V Pecot; Alexander V Kabanov
Journal:  Sci Adv       Date:  2020-06-17       Impact factor: 14.136

5.  Theoretical Studies on the Engagement of Interleukin 18 in the Immuno-Inflammatory Processes Underlying Atherosclerosis.

Authors:  Dorota Formanowicz; Kaja Gutowska; Piotr Formanowicz
Journal:  Int J Mol Sci       Date:  2018-11-05       Impact factor: 5.923

Review 6.  Metabolic Programming of Macrophages: Implications in the Pathogenesis of Granulomatous Disease.

Authors:  Jayne Louise Wilson; Hannah Katharina Mayr; Thomas Weichhart
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

Review 7.  IL-10 in glioma.

Authors:  Samuel S Widodo; Marija Dinevska; Liam M Furst; Stanley S Stylli; Theo Mantamadiotis
Journal:  Br J Cancer       Date:  2021-08-04       Impact factor: 9.075

Review 8.  Future Challenges in Cancer Resistance to Immunotherapy.

Authors:  Marit J van Elsas; Thorbald van Hall; Sjoerd H van der Burg
Journal:  Cancers (Basel)       Date:  2020-04-10       Impact factor: 6.639

9.  Toxicity of TiO2 Nanoparticles: Validation of Alternative Models.

Authors:  Mélanie M Leroux; Zahra Doumandji; Laetitia Chézeau; Laurent Gaté; Sara Nahle; Romain Hocquel; Vadim Zhernovkov; Sylvie Migot; Jafar Ghanbaja; Céline Bonnet; Raphaël Schneider; Bertrand H Rihn; Luc Ferrari; Olivier Joubert
Journal:  Int J Mol Sci       Date:  2020-07-09       Impact factor: 5.923

Review 10.  The Role of an IL-10/Hyaluronan Axis in Dermal Wound Healing.

Authors:  Kavya L Singampalli; Swathi Balaji; Xinyi Wang; Umang M Parikh; Aditya Kaul; Jamie Gilley; Ravi K Birla; Paul L Bollyky; Sundeep G Keswani
Journal:  Front Cell Dev Biol       Date:  2020-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.